Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/23091724
Conclusion of this study
In healthy volunteers, smoking blunts vascular function mirrored by a decrease in FMD and an increase in sVCAM-1. Short-term treatment with benfotiamine significantly reduces these effects, showing protective vascular properties.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
